# Prothya Biosolutions Netherlands B.V., Amsterdam, Netherlands – FDA Inspections

Source: https://www.keypedia.com/companies/prothya-biosolutions-netherlands-bv/6a382cff-b7f3-41f4-8bb9-f1bad922313f

> Inspection records and compliance data for Prothya Biosolutions Netherlands B.V. in Amsterdam. 6 FDA inspections on record (3 OAI), 1 Form 483, last inspected March 30, 2018.

---

## Details

- Name: Prothya Biosolutions Netherlands B.V.
- FEI Number: 3007166802
- Address Line 1: Plesmanlaan 125
- City: Amsterdam
- Country Name: Netherlands
- Address: Plesmanlaan 125, Amsterdam, Netherlands
- Country: Netherlands

## Related Documents

- [EMA GMP - Prothya Biosolutions Netherlands B.V. - NL/H 24/2007723 - 2025-10-08](https://www.keypedia.com/records/ema/prothya-biosolutions-netherlands-bv/29f9a144-1471-4da4-9e8f-1a1d943cd700) — source: EMA, date: October 8, 2025
- [FDA Inspection 1046705 - Prothya Biosolutions Netherlands B.V. - 2018-03-30](https://www.keypedia.com/records/fda_inspections/prothya-biosolutions-netherlands-bv/6a833c0f-cc25-48db-8a06-a2cc09695495) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 30, 2018
- FDA Inspection 969120 - Prothya Biosolutions Netherlands B.V. - 2016-05-13 — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 13, 2016
- [FDA Inspection 906173 - Prothya Biosolutions Netherlands B.V. - 2014-11-20](https://www.keypedia.com/records/fda_inspections/prothya-biosolutions-netherlands-bv/3b7af2f8-afcc-4f9f-bc35-22aa3a72c00a) — classification: Official Action Indicated (OAI), source: FDA, date: November 20, 2014
- [FDA Inspection 835110 - Prothya Biosolutions Netherlands B.V. - 2013-06-04](https://www.keypedia.com/records/fda_inspections/prothya-biosolutions-netherlands-bv/23e6a9c5-f5f5-4b5c-b50d-c5e4adc3f6ce) — classification: Official Action Indicated (OAI), source: FDA, date: June 4, 2013
- [FDA Inspection 748170 - Prothya Biosolutions Netherlands B.V. - 2011-09-28](https://www.keypedia.com/records/fda_inspections/prothya-biosolutions-netherlands-bv/f372e9c5-c56e-4140-9d62-be0f3266f372) — classification: Official Action Indicated (OAI), source: FDA, date: September 28, 2011
- FDA Inspection 620661 - Prothya Biosolutions Netherlands B.V. - 2009-09-15 — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 15, 2009

## Related Companies

- [Protherics UK Limited](https://www.keypedia.com/companies/protherics-uk-limited/ad10cdb3-3b0a-464d-bc88-0dee94941d89)
- [Gilead Sciences, Inc.](https://www.keypedia.com/companies/gilead-sciences-inc/131b7354-e305-4657-bb80-8d2960346ba7)
- [Precigen Inc](https://www.keypedia.com/companies/precigen-inc/4e287f51-098f-4643-9b3f-0456ce72600e)
- [Oxford Biomedica (UK) Limited](https://www.keypedia.com/companies/oxford-biomedica-uk-limited/5d00efc3-e665-40cf-96db-03c38ca19f3f)
- [Novartis Pharmaceutical Manufacturing GmbH](https://www.keypedia.com/companies/novartis-pharmaceutical-manufacturing-gmbh/2259b2e5-2c88-47ad-9c09-2add30d0397c)
- [GenTrac, Inc.](https://www.keypedia.com/companies/gentrac-inc/6649d47e-f060-44e5-9c19-488234df324f)
- [ModernaTX, Inc.](https://www.keypedia.com/companies/modernatx-inc/8d0092a3-f330-4ddf-ae1f-f4dd9c0aba6e)
- [MedImmune U.K. Limited](https://www.keypedia.com/companies/medimmune-uk-limited/fbddd1ed-5a0c-4c65-a48e-bb2af79482ed)
- [Spark Therapeutics, Inc.](https://www.keypedia.com/companies/spark-therapeutics-inc/a5518493-a117-41d3-862d-96d5a5d3b6dd)
- [Dynavax GmbH](https://www.keypedia.com/companies/dynavax-gmbh/3c69b2a7-44b1-4674-8038-963c355c138f)